ChemoCentryx, Inc.
ChemoCentryx, Inc. (CCXI) is a publicly traded company in the Unknown sector. Across all available filings, 26 corporate insiders have executed 1000 transactions totaling $515.0M, demonstrating a bearish sentiment with -$487.6M in net insider flow. The most recent transaction on Oct 20, 2022 involved a transaction of 10,870 shares valued at $0.
CCXI Insider Activity Summary
Who Is Buying CCXI Stock?
No significant insider buying has been recorded for CCXI in the recent period.
Who Is Selling CCXI Stock?
No significant insider selling has been recorded for CCXI in the recent period.
Is ChemoCentryx, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CCXI is bearish with an Insider Alignment Score of 3/100 and a net flow of -$487.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CCXI Frequently Asked Questions
Understanding CCXI Insider Activity
Insider trading at ChemoCentryx, Inc. (CCXI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 26 insiders are actively trading CCXI stock, having executed 1000 transactions in the past 90 days. The most active insider is Fresenius Medical Care Renal Pharma Ltd. Vifor (Executive), who has made 29 transactions totaling $188.1M.
Related Tools
Track ChemoCentryx, Inc. Insider Activity
Get notified when executives and directors at CCXI file new Form 4 transactions